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Summary
The finding of orexin/hypocretin deficiency in narco-
lepsy patients suggests that this hypothalamic neuro-
peptide plays a crucial role in regulating sleep/wake-
fulness states. However, very little is known about
the synaptic input of orexin/hypocretin-producing
neurons (orexin neurons). We applied a transgenic
method to map upstream neuronal populations that
have synaptic connections to orexin neurons and re-
vealed that orexin neurons receive input from several
brain areas. These include the amygdala, basal fore-
brain cholinergic neurons, GABAergic neurons in the
preoptic area, and serotonergic neurons in the me-
dian/paramedian raphe nuclei. Monoamine-contain-
ing groups that are innervated by orexin neurons do
not receive reciprocal connections, while cholinergic
neurons in the basal forebrain have reciprocal con-
nections, which might be important for consolidating
wakefulness. Electrophysiological study showed that
carbachol excites almost one-third of orexin neurons
and inhibits a small population of orexin neurons.
These neuroanatomical findings provide important in-*Correspondence: stakeshi@md.tsukuba.ac.jpsights into the neural pathways that regulate sleep/
wakefulness states.
Introduction
Sleep/wakefulness states of mammals are regulated by
several brain areas. Monoaminergic neurons, which
constitute diffuse projection systems arising from the
brainstem/hypothalamus and innervating diffuse areas
of the brain, have been predicted to be important for
maintenance of wakefulness. These neurons include
noradrenergic cells in the locus coeruleus (LC), sero-
tonergic cells in the dorsal raphe nucleus (DR), and his-
taminergic cells in the tuberomammillary nucleus (TMN),
which are all active during wakefulness, less active dur-
ing non-REM sleep, and almost silent during REM
sleep. Cholinergic neurons in the brainstem (laterodor-
sal tegmental/pedunculopontine tegmental nuclei [LDT/
PPT]) are also implicated in sleep/wake regulation; a
group of cholinergic neurons in the LDT/PPT, which are
silent in wakefulness and active in the REM period,
constitute a system to induce and maintain REM sleep.
Another type of cholinergic neurons, which are active
in wakefulness as well as in the REM sleep period, were
also found in the PPT/LDT. On the other hand, the
ventrolateral preoptic nucleus (VLPO) contains inhibi-
tory neurons that are active during sleep and are neces-
sary for normal sleep (Chou et al., 2002; Gallopin et
al., 2000).
More recently, neurons located in the lateral hypo-
thalamic area (LHA) that produce hypothalamic neuro-
peptides, orexins/hypocretins, have been shown to
be a highly important regulator of sleep/wakefulness
states (Sakurai, 2003; Sakurai et al., 1998; Willie et al.,
2001). Deficiency of orexin signaling causes a sleep
disorder, narcolepsy, in animal models as well as hu-
mans (Chemelli et al., 1999; Hara et al., 2001; Lin et al.,
1999; Peyron et al., 2000; Thannickal et al., 2000; Willie
et al., 2003). The implication of orexin/hypocretin in
narcolepsy suggests the importance of orexin in the
normal regulation of vigilance states. Orexin-contain-
ing neurons (orexin neurons) are exclusively localized
within the LHA and project to numerous brain regions.
Especially strong innervation by orexin-immunoreactive
(orexin-ir) fibers was observed in the LC, DR, TMN, and
LDT/PPT (Date et al., 1999; Nambu et al., 1999; Peyron
et al., 1998), suggesting that orexin neurons affect the
activity of these nuclei to regulate sleep/wakefulness
states.
To further understand the physiological roles of
orexin neurons, we need to know the mechanisms by
which the activity of orexin neurons is regulated. How-
ever, very little has been known about the synaptic in-
puts of these cells. Afferents to these cells are difficult
to study, because the cells are dispersed medial-later-
ally within the LHA. In this study, we generated trans-
genic mouse lines expressing a fusion protein between
the nontoxic C-terminal fragment of tetanus toxin (TTC)
and GFP (TTC::GFP) exclusively in orexin neurons. This
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nected neurons in a retrograde direction and trans-
ported to the cell bodies of higher-order neurons
(Maskos et al., 2002). This approach allowed us to visu-
alize, at single-cell resolution, neurons that send synap-
tic projections to orexin neurons, by visualizing GFP in
interconnected neural circuits. We identified GFP-posi-
tive cells in multiple specific brain regions, including
the basal forebrain cholinergic neurons, GABAergic
neurons in the VLPO, and serotonergic neurons in the
median raphe (MnR) and paramedian raphe (PMnR) nu-
cleus. We also found that almost 20% of orexin neurons
examined were activated by a cholinergic agonist, car-
bachol, while 3% of orexin neurons were inhibited.
These anatomical and functional observations revealed
neural networks that regulate the activity of orexin neu-
rons, and provide important insights into the pathways
that regulate vigilance states.
Results
Expression of TTC::GFP Fusion Protein
in Orexin Neurons
We constructed a transgene with the human prepro-
orexin promoter, which was ligated to the DNA frag-
ment encoding TTC::GFP (Figure 1A). This promoter
has been shown to direct expression of exogenous pro-
teins specifically in orexin neurons (Hara et al., 2001;
Moriguchi et al., 2002; Sakurai et al., 1999; Yamanaka
et al., 2003a). Brains from 8- to 12-week-old mice were
tested for expression of the transgene product. We ob-
served strong expression of GFP fluorescence in the F
OLHA of the transgenic mice by fluorescent microscopy
(Figure 1B). In this study, we coinjected the orexin/lacZ (
sconstruct (Sakurai et al., 1999) when we made the
ptransgenic lines, so that we could monitor the site of
atransgene expression by β-galactosidase staining. The
(β-galactosidase staining of brains of orexin/TTC::GFP n
lines showed that LacZ expression was exclusively ob- d
served in orexin-ir neurons (Figure 1C). We extensively a
(searched expression of the transgene throughout the
htransgenic mouse brains by in situ hybridization histo-
schemistry using a riboprobe for GFP, but we did not
p
observe the expression of the transgene except for the (
LHA regions (Figure 1D). These observations suggest o
that the transgene is expressed exclusively in β
torexin neurons.
b
pSelective Transfer of TTC::GFP Fusion Protein o
to Synaptic Terminals on Orexin Neurons e
We confirmed the retrograde transfer of the TTC::GFP h
lfusion protein from orexin neurons to terminals that
(make synapses in orexin neurons, by immunoelectron
mmicroscopy with anti-GFP antiserum. In the LHA, many
tneurons that showed very strong immunoreactivity for s
GFP in their cytoplasm were observed. These neurons H
are orexin neurons, because we found that all strongly l
pimmunoreactive neurons in the LHA are orexin neurons
L(Figure 1B). Using immunoelectron microscopy, we ex-
tensively observed the hypothalamic regions in which
orexin neurons are distributed, to confirm selective i
dtransfer of the fusion protein. Over 100 sections
throughout the hypothalamus were cut, and further cut tigure 1. Transgenic Mice Expressing TTC::GFP Fusion Protein in
rexin Neurons
A) Structure of orexin/TTC::GFP transgene. SP, human ICAM signal
equence; TTC, tetanus toxin C-terminal fragment; mPrmI, murine
rotamine-1 gene fragment containing 3# half of exon 1, intron 1,
nd exon 2.
B) Expression of TTC::GFP fusion protein by orexin-containing
eurons in LHA of orexin/TTC::GFP transgenic mice, shown by
ouble-label immunofluorescence. (Left panel) GFP-like immunore-
ctivity (GFP-ir) (green). (Middle panel) Orexin-like immunoreactivity
orexin-ir) (red). (Right panel) Merged image. Lower panels show
igh-power views of region shown in yellow rectangles in corre-
ponding upper panels. Arrows show local interneurons, which are
ositive for GFP-ir and negative for orexin-ir. Scale bar, 50 m.
C) Colocalization of β-galactosidase and orexin-ir in the LHA of
rexin/TTC::GFP transgenic mice shown by double labeling by
-galactosidase staining (blue) and orexin-ir (brown). Because
hese two transgenes were integrated in the same locus and driven
y the same promoter, we could monitor the site of transgene ex-
ression by β-galactosidase staining. The β-galactosidase staining
f brains of orexin/TTC::GFP lines showed that the transgene was
utopically expressed by orexin neurons. The right panel shows a
igh-power view of the region shown in the yellow rectangle in the
eft panel. Scale bar, 50 m.
D) In situ hybridization histochemistry showing that the transgene
RNA is exclusively localized in the LHA. Coronal sections of the
ransgenic mouse brains hybridized with digoxigenin-labeled anti-
ense probe for GFP. (Left panel) Low-power field. (Right panel)
igher-power field of the regions shown by yellow rectangle in the
eft panel. No signal beyond background was generated by sense
robe (data not shown). We did not detect any signals outside the
HA in the all transgenic lines.nto serial ultrathin sections, which were observed un-
er an electron microscope, and all DAB-positive reac-
ions were observed and photomicrographed. GFP-like
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299immunoreactivity (GFP-ir) was found in vesicle-like
structures in the cytoplasm (Figure 2D). GFP-ir synaptic
terminals that made synapses on GFP-positive soma
or dendrites were observed. The fusion protein accu-
mulates in the postsynaptic membrane in a punctate
intraneuronal pattern. Immunoreactivity was continu-
ously observed in the presynaptic membrane, and in
the cytoplasm of synaptic boutons, suggesting that the
fusion protein was transported from cell bodies to syn-
aptic boutons in a retrograde manner (Figure 2C).
These observations suggest that transfer of the fusion
protein selectively occurs in synapses. On the other
hand, we did not observe GFP-ir in the synaptic ter-
minals that made synapses on GFP-negative soma or
dendrites in the LHA.
Orexin Neurons Are Innervated
by Local Interneurons
In the LHA region, where orexin neurons are distributed,
almost all cells that showed strong GFP fluorescence
were also positive for orexin-ir. On the other hand, al-
most all orexin-ir cells showed bright GFP fluorescence
(Figure 1B). However, double-labeled immunofluores-
cence analysis demonstrated small numbers of neu-
rons that were positive for GFP-ir and negative for
orexin-ir, suggesting the existence of local interneurons
with synaptic connections to orexin neurons (Figure
1B). Relatively many such neurons were observed in
the medial region of the LHA. Generally, these neurons
were smaller than orexin neurons and showed much
weaker staining for GFP-ir.Figure 2. Retrograde Transfer of TTC::GFP Fusion Protein from Cell
Bodies to Synaptic Terminals Revealed by Immunoelectron Mi-
croscopy Using Anti-GFP Antiserum
(A) Electron micrograph showing a GFP-ir cell body receiving a syn-
apse from a GFP-ir axon terminal. Perinuclear vesicle-like struc-
tures are intensely immunostained in the cell body (expression ori-
gin). The cytoplasm in a synaptic terminal making a synapse on the
GFP-ir soma also contains strongly immunoreactive vesicles. Pre-
and postsynaptic membranes are both strongly stained, showing
that the fusion protein is transferred trans-synaptically.
(B) Schematic drawing of (A) Mt, mitochondria. Scale bar, 1 m.
(C and D) High-power views of regions shown by rectangles in (A).
Arrowhead shows the synapse structure. Arrows show immuno-
stained vesicle-like structures.Distribution of GFP-ir in Brain
of Orexin/TTC::GFP Mice
The GFP fluorescence of retrogradely labeled neurons
was very weak. Therefore, we stained the brains of 8-
to 12-week-old transgenic mice with anti-GFP serum to
detect GFP with higher sensitivity. This method allowed
us to examine the more detailed distribution of the fu-
sion protein (Figure 3). We examined the distribution of
GFP-ir in over 20 brains prepared from three indepen-
dent lines. We recognized positive expression only
when positive neurons were observed in all lines con-
sistently.
A small number of medium to large sized (10–15 m)
cell bodies with positive staining were observed in the
infralimbic (IL) and prelimbic (PrL) cortex (Figure 3B).
Many positively stained cell bodies were observed in
the amygdaloid regions, including the central (Ce), me-
dial, basomedial (BMA), and anterior cortical amygda-
loid nucleus (Aco) and the basolateral amygdaloid nu-
cleus (BLA) (Figures 3E–3H). Many labeled cells were
observed in the shell region of the nucleus accumbens
(AcbSh) (Figure 3B). Many heavily labeled stained cells
were also observed in the bed nucleus of the stria ter-
minalis (BST), especially in the anterior part of the me-
dial division and the ventral part of the lateral division
(Figure 3D; see also Figure S3 in the Supplemental Data
available with this article online).
In the septal regions, many densely stained cells
were observed in the medial and lateral septal nuclei
(MS and LS) (Figure 3C).
The POA, including the medial and lateral preoptic
areas (MPO and LPO), contained many densely labeled
cells (Figures 3D and 3E). Several densely stained cells
were observed in the VLPO. In the thalamus, several
stained cells were observed in the medial part of the
lateral habenular nucleus (LHb) (Figure 3H). Positive
cells were not observed in other regions of the thala-
mus. Many densely stained cells were also observed in
the magnocellular preoptic nucleus (MCPO) (Figure 3D).
In the hypothalamus, many densely stained cells
were observed in the lateroanterior hypothalamus (LA)
(Figure 3E). The LHA contained many very strongly la-
beled cells, which might be the origin of expression
(orexin neurons). No positively stained cells were ob-
served in the suprachiasmatic nucleus (SCN). A small
number of positive cells were observed in the retrochi-
asmatic area. Many stained cells were also observed in
the arcuate nucleus (Figures 3G and 3H), consistent
with previous reports showing that orexin neurons in
the LHA receive terminal appositions from neuropep-
tide Y (NPY)- and α-melanocyte-stimulating hormone
(α-MSH)-immunoreactive fibers (Broberger et al., 1998;
Elias et al., 1998). Many stained neurons were also ob-
served in the ventromedial hypothalamus (VMH) and
dorsomedial hypothalamus (DMH) (Figures 3G and 3H).
A moderate number of positive cells were observed in
the paraventricular nucleus (PVN). More caudally, many
labeled cells were observed in the posterior hypothala-
mus (PH) (Figure 3H).
A few stained cells were observed in the LDT/PPT
(Figure 3L). Several cells with moderately dense stain-
ing were observed in the vestibular nucleus. Only a few
labeled cells were observed in the DR.
The midbrain tegmental nucleus (MiTg) contained
Neuron
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Schematic drawings of localization of TTC::GFP fusion protein from rostral (A) to caudal (O) in transgenic mouse brain rostrocaudal coronal
sections revealed by immunohistochemical staining using anti-GFP antiserum. Blue stars, orexin neurons. Red dots, weakly or moderately
stained cells. Red squares, strongly stained cell bodies. 7N, facial nucleus; 8vn, vestibular root of vestibulocochlear nerve; 10N, dorsal motor
nucleus of vagus; aci, anterior commissure, intrabulbar; aca, anterior commissure, anterior part; AcbSh, accumbens nucleus, shell region;
Aco, anterior cortical amygdaloid nucleus; AHP, anterior hypothalamic area; Arc, arcuate hypothalamic nucleus; BLA, basolateral amygdaloid
nucleus; BMA, basomedial amygdaloid nucleus, anterior part; BMP, basomedial amygdaloid nucleus, posterior part; BST; bed nucleus of stria
terminalis; C1, C1 adrenaline cells; Ce, central amygdaloid nucleus; cp, cerebral peduncle; D3, dorsal third ventricle; DG, dentate gyrus; DM,
dorsomedial hypothalamic nucleus; DR, dorsal raphe nucleus; f, fornix; HDB, nucleus of horizontal limb of diagonal band; IL, infralimbic
cortex; IS, inferior salivatory nucleus; LA, lateroanterior hypothalamic nucleus; LC, locus coeruleus; LDT, laterodorsal tegmental nucleus; LH,
lateral hypothalamus; LHb, lateral habenular nucleus; lo, lateral olfactory tract; LRt, lateral reticular field; LV, lateral ventricle; m5, motor root of
trigeminal nerve; MCPO, magnocellular preoptic nucleus; ml, medial lemniscus; MiTg, microcellular tegmental nucleus; mlf, medial longitudinal
fasciculus; MnR, median raphe nucleus; Mo5, motor tegmental nucleus; MPO, medial preoptic area; MS, medial septal nucleus; mt, mammillo-
thalamic tract; MTu, medial tuberal nucleus; NTS, nucleus of solitary tract; PAG, periaqueductal gray PH, posterior hypothalamus; Pir, piriform
cortex; PMCo, posteromedial cortical amygdaloid nucleus; PPT, pedunculopontine tegmental nucleus; PrL, prelimbic cortex; py, pyramidal
tract; RMg, raphe magnus nucleus; Rpa, raphe pallidus nucleus; Sch, suprachiasmatic nucleus; SNC, substantia nigra, compact part; SNR,
substantia nigra, reticular part; SO, supraoptic nucleus; sol, solitary tract; sp5, spinal trigeminal tract; st, stria terminalis; SuM, supramammil-
lary nucleus; TMN, tuberomammillary nucleus; Tu, olfactory tubercle; VDB, nucleus of vertical limb of diagonal band; VLPO, ventrolateral
preoptic area; VMH, ventromedial hypothalamic nucleus; VTA, ventral tegmental area.
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301several stained cells (Figure 3K). Many cells with GFP-
ir were observed in the MnR and PMnR (Figures 3K
and 3L).
No positive cells were observed in any region of the
cerebellum.
Orexin Neurons Are Innervated
by Cholinergic Neurons
Since we observed labeled neurons in several brain re-
gions known to contain particular neurotransmitters,
we examined the colocalization of these neurotransmit-
ters and GFP-ir in these regions by double-label immu-
nohistochemistry. Many heavily stained cells were ob-
served in areas in which the basal forebrain cholinergic
neurons are located, including the basal nucleus of
Meynert, medial septal nucleus (MS), vertical and hori-
zontal limb of the diagonal band nucleus (VDB and
HDB), and magnocellular preoptic nucleus (MCPO)
(Figure 4). We found that essentially all GFP-ir cells in
these regions also showed choline acetyl transferase
(ChAT)-like immunoreactivity (ChAT-ir) (Figure 4E). In the
basal nucleus of Meynert, MS, VDB, HDB, and MCPO,
33% ± 6%, 18% ± 5%, 13% ± 5%, 16% ± 6%, and
15% ± 8% of ChAT-positive cells were positive for GFP-
ir, respectively (n = 4). These observations suggest that
a subpopulation of the basal forebrain cholinergic neu-
rons send innervations to orexin neurons.
In contrast, only a few faintly stained cells were ob-
served in the PPT/LDT. These GFP-ir cells in the PPT/
LDT were also positive for ChAT-ir (Figure 4E), while
2% ± 0.6% of ChAT-ir cells in these regions were posi-
tive for GFP-ir (n = 3).
We also observed many GFP/ChAT-double-positive
cells in the DMH (Figure 4E).
Effects of Carbachol on Orexin Neurons
Cholinergic neurons are thought to play an important
role in the maintenance of wakefulness. Therefore, we
next examined the effect of cholinergic innervation on
orexin neurons in detail. We studied the effects of car-
bachol, a muscarinic agonist, on a large number of ore-
xin neurons to examine how many of these neurons are
affected by carbachol. We used orexin/EGFP mice (Li
et al., 2002; Yamanaka et al., 2003a; Yamanaka et al.,
2003b) for recording of orexin neurons. In 250 m thick
slice preparations, from successive regions of the hy-
pothalamus, fluorescing orexin neurons were subjected
to whole-cell patch-clamp recording. We found that
orexin neurons showed various responses to car-
bachol. Carbachol (100 M) induced depolarization in
20% (20/104) of orexin neurons examined and induced
hyperpolarization in 3% (3/104) of orexin neurons ex-
amined during current-clamp recording (Figures 5A and
5B). The remaining population of orexin neurons did not
detectably respond to carbachol. Consistently, car-
bachol evoked an inward current in 27% (41/152) of or-
exin neurons when examined by voltage clamp (Vh =
−60 mV) (Figure S1). This effect was concentration de-
pendent (Figure 5C) and was concentration depen-
dently inhibited by a muscarinic antagonist, atropine
(data not shown). The reversal potential examined from
the I-V relationship obtained by a voltage ramp protocol
in the presence of tetrodotoxin was −11.0 ± 2.5 mV (n =Figure 4. Cholinergic Neurons Send Input to Orexin Neurons
GFP-positive neurons in cholinergic cells in orexin/TTC::GFP trans-
genic mouse brains are demonstrated by immunohistochemical
staining using anti-GFP antiserum. Scale bars, 50 m. (A) Coronal
brain section at approximately bregma +1.1 mm stained with anti-
GFP antibody. (B) High-power view of region shown in yellow rec-
tangle in (A). Several strongly stained cells are observed in the ver-
tical and horizontal limb of the diagonal band nucleus (VDB and
HDB). (C) Coronal brain section at approximately bregma −0.7 mm
stained with anti-GFP antibody. (D) High-power view of region
shown in yellow rectangle in (C). The basal nucleus of Meynert con-
tains many strongly stained cells. BLA, basolateral amygdaloid nu-
cleus; BMA, basomedial amygdaloid nucleus; opt, optic tract. (E)
Colocalization of GFP-ir and choline acetyl transferase (ChAT)-ir in
transgenic mouse. (Left panels) GFP-positive neurons are stained
with green fluorescence (Alexa 488). (Middle panels) ChAT-positive
cells are stained with red fluorescence (Alexa 594). (Right panels)
Merged image. Colocalization of GFP-ir and ChAT-ir in VBD/HBD
region, basal nucleus of Meynert, LDT, and DMH is shown. The
number of GFP-ir cells in the LDT/PPT was very small, but these
cells showed ChAT-ir (shown by arrow).4), suggesting that carbachol activates nonselective
cation channels (Figure S1). On the other hand, car-
bachol induced an outward current in a small popula-
tion of orexin neurons examined (9/152). This effect was
concentration dependent (Figure 5D) and was concen-
tration dependently inhibited by a muscarinic antago-
nist, atropine (data not shown). The reversal potential
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Effects of a muscarinic agonist, carbachol, on GFP-expressing
orexin neurons in hypothalamic slice preparations from orexin/ a
EGFP transgenic mice (Yamanaka et al., 2003a; Yamanaka et al., (
2003b). (A and B) The effect of carbachol was analyzed in current- 5
clamp mode in the absence (upper panels) or presence (lower pan-
iels) of tetrodotoxin (1 M). Orexin neurons showed a variety of re-
nsponses to carbachol: 27% showed depolarization (A), 6% showed
whyperpolarization (B), and 67% showed no effect (data not shown).
(C) Relationship between peak inward current (pA) (mean ± SD) g
and concentration of carbachol (n = 10) in orexin neurons in which w
carbachol evoked an excitatory effect. Holding potential (Vh) was s
clamped at −60 mV. (D) Relationship between peak outward current
1(pA) (mean ± SD) and dose of carbachol (n = 10) in orexin neurons
sin which carbachol evoked an inhibitory effect. Holding potential
m(Vh) was −60 mV. (E) Distribution of orexin neurons showing depo-
larization (excitatory; red circles), hyperpolarization (inhibitory; b
green circles), or no effect (blue circles) of carbachol application
during current clamp, analyzed in several successive slice prepara- L
tions from the rostral, middle, or caudal region of the hypo- ithalamus.
N
t
odetermined from the I-V relationship obtained by a volt-
age ramp protocol was −114 ± 15.4 mV (n = 3), which 1
eis similar to the theoretical K+ equilibrium potential (116
mV) (Figure S1). n
sThese observations suggest that cholinergic innerv-
ations excite almost 20% of orexin neurons by activa- a
pting nonselective cation channels, and inhibit a small
population of orexin neurons by activating potassium p
tchannels. Cells that responded to carbachol were equ-
ally distributed in every section from rostral to caudal, plthough the middle region contained a relatively large
umber of cells that were activated by carbachol (Fig-
re 5C).
rexin Neurons Are Innervated by GABAergic
eurons in Preoptic Area
he POA, including the MPO and LPO, contained many
ensely labeled neurons (Figure 6A). Notably, several
ensely stained cells were observed in the VLPO (Fig-
re 6B).
The POA, especially the VLPO, is reported to contain
leep-active neurons, which carry inhibitory neuro-
ransmitters, GABA and galanin. We previously found
hat GABA potently inhibits orexin neurons, while ga-
anin does not show a detectable effect on the activity
f orexin neurons (Yamanaka et al., 2003a). Therefore,
e examined if these retrogradely labeled cells in the
LPO contain GABA or not. By double-label immuno-
luorescent study, we found several GFP- and GABA-
ouble-positive cells within the VLPO in the brains of
he transgenic mice (Figure 6C). Almost 8.2% ± 1.6%
f GABA-ir cells in these regions were positive for GFP-
r (n = 3). These observations suggest that VLPO neu-
ons send GABAergic inhibitory projections to orexin
eurons.
rexin Neurons Are Innervated by 5-HT Neurons
n Raphe Nuclei
any cells with dense signals for GFP-ir were observed
n the MnR and PMnR nucleus (Figures 7A and 7B). A
oderate number of heavily stained cells were also ob-
erved in the raphe pallidus (Rpa) and raphe magnus
RMg) nuclei (Figure 3M). In contrast, few positive cells
ere observed in the DR.
In the MnR, 66% ± 4% of GFP-positive cells were
lso positive for 5-HT immunoreactivity (5-HT-ir) (n = 4)
Figure 7C). Of 5-HT-positive cells in the MnR, 47% ±
% were positive for GFP (n = 3), suggesting strong
nteractions between orexin neurons and serotonergic
eurons in the MnR. Several GFP-positive cells that
ere negative for 5-HT-ir were also observed in this re-
ion. In contrast, no GFP/5-HT-double-positive cells
ere observed in the DR (Figure 7C), where dense
taining of orexin-ir fibers was observed (Date et al.,
999; Nambu et al., 1999; Peyron et al., 1998). We ob-
erved amorphous staining of GFP-ir in the DR, which
ight represent axons of orexin neurons, but the num-
er of labeled cell bodies was small (Figure 7C).
abeled Neurons Were Not Observed
n LC and TMN
otably, no positively stained cells were observed in
he LC (Figure S2), where very dense projections of
rexin-positive nerve fibers were observed (Date et al.,
999; Marcus et al., 2001; Nambu et al., 1999; Peyron
t al., 1998; Yamanaka et al., 2002). Positive cells were
ot observed in the TMN either. Instead, amorphous
taining was observed in these regions, which might be
xon terminals of orexin neurons, because the fusion
rotein is transported along their axons. Similarly, GFP-
ositive cells were not detected in TH-positive cells in
he ventral tegmental area (VTA) (We observed several
ositive cells in the most caudal part of the VTA, but
Afferents of Orexin Neurons
303Figure 6. Neurons in POA Send Input to
Orexin Neurons
(A) Preoptic area of transgenic mouse brain
section at approximately bregma +0.02 mm
stained with anti-GFP antibody. MPO, medial
preoptic area; LPO, lateral preoptic area.
(B) Ventrolateral preoptic area (VLPO) con-
tains several cells densely labeled with anti-
GFP antiserum. Scale bar, 50 m.
(C) Double-immunofluorescence analysis
showing that most GFP-positive neurons in
the VLPO region contain GABA-ir. (Left
panel) GFP-ir neurons in VLPO region in
transgenic mouse brain. (Middle panel)
GABA-ir observed in same brain section.
Scale bar, 50 m. (Right panel) Merged
image.amongst various types of cells. In the present study, we ond-order upstream neurons; therefore, the labeling
Figure 7. Immunohistochemical Study Show-
ing that Serotonergic Cells in MnR Send In-
put to Orexin Neurons
(A) Median raphe nucleus of coronal section
of transgenic mouse brain at approximately
bregma −4.4 mm stained with anti-GFP an-
tibody.
(B) High-power view of region shown in yel-
low rectangle in (A). Scale bar, 50 m.
(C) (Upper panels) Colocalization of GFP-ir
and 5-HT-ir in the median raphe (MnR). (Left
panels) GFP-positive neurons are stained
with green fluorescence (Alexa 488). (Middle
panels) 5-HT-positive cells are stained with
red fluorescence (Alexa 594). (Right panels)
Merged image. Arrows show examples of
5-HT-positive cells that also contain GFP-ir.
(Lower panels) GFP-ir cells were not ob-
served in DR, although amorphous GFP-ir
staining was observed in this region. Scale
bars, 50 m. Aq, aqueduct.these cells were not tyrosine hydroxylase [TH] positive.)
(Figure S2). In contrast, some TH- and GFP-double-
positive cells were observed in the A1 noradrenergic
region under the same staining conditions (Figure S2).
Discussion
Technical Considerations
Afferents to orexin neurons are difficult to study, be-
cause the cells are diffusely distributed within the LHAused the GFP::TTC transgene to identify orexin neu-
ronal afferents (Maskos et al., 2002). We utilized this
technique using the human orexin promoter, which has
the property to express exogenous genes specific to
orexin neurons (Hara et al., 2001; Moriguchi et al., 2002;
Sakurai et al., 1999; Yamanaka et al., 2003a). This fusion
protein has the property of passing from one neuron to
an interconnected one in a retrograde manner without
anterograde transfer (Maskos et al., 2002). This fusion
protein was reported to be transferred to at least sec-
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304might contain secondary or higher-order neurons (Mas- v
nkos et al., 2002). However, the staining of intercon-
nected neurons was much weaker than that of the ex-
apression origin (orexin neurons). We thus thought that
strong retrograde labeling is observed mainly in first- t
2order neurons, although some faintly labeled neurons
might possibly be second- or higher-order neurons. t
bMaskos et al. did not examine the possibility that
TTC::GFP could be secreted by neurons and taken up t
Cby terminals, which in fact do not innervate the expres-
sion origin(s) but innervate adjacent neurons. There- v
mfore, care is needed regarding the possibility of false
positives. We performed immunoelectron microscopic o
tanalysis of the fusion protein in the LHA of the trans-
genic mice using anti-GFP antiserum. Electron mi- c
lcroscopy showed that cell-to-cell transfer of the fusion
protein selectively occurred in synapses between GFP- s
bir dendrites or soma and terminals that made synapses
on them (Figure 2). This observation suggests that this o
bmethod can precisely label the upstream neurons that
make synapses on orexin neurons.
nAlthough we could not detect any ectopic expression
of the transgene by in situ hybridization or lacZ staining p
lin all lines (Figures 1C and 1D), a very low level of ec-
topic expression, which can not be detected by in situ m
Thybridization but can be detected by GFP immuno-
staining, might still exist. The false positive might be e
rdependent on the positional effects of the transgene.
Therefore, we rigorously examined the distribution of t
sGFP-ir in over 20 brains prepared from three indepen-
dent lines. We also stained wild-type brains as a nega-
ptive control. We recognized expression as “positive”
only when GFP-ir was consistently detected in brains T
rprepared from all lines. We recognized positive expres-
sion only when positive neurons were observed in all s
rlines consistently. We observed few positive cells in
several areas of the neocortex, hippocampus, and stri- w
tatum in brains of line E3, but we did not detect positive
neurons in most areas of the striatum and neocortex in s
the other two lines, excluding the IL and PrL cortex in
line D1. Positive cells seen in the neocortices, hippo- O
campus, and striatum in line E3 might be false positive. N
Alternatively, these might be higher-order neurons, T
which could be only labeled in line E3, because this line g
shows relatively strong expression of transgene com- b
pared with other lines. c
S
wOrexin Neurons Are Innervated
by Cholinergic Neurons (
eThe cholinergic system of the basal forebrain is hypoth-
esized to play an important role in arousal through a t
Mgeneral activating effect on the cortical mantle (Alam et
al., 1999). The majority of cholinergic neurons in the p
1basal forebrain of cats and rats exhibit increased dis-
charge rates during both wakefulness and REM sleep, t
wand diminished discharge during non-REM sleep (Szy-
musiak et al., 2000; Thakkar et al., 2003). Our present t
Gwork revealed that some populations of the cholinergic
neurons in the MS, VDB, HDB, MCPO, and basal nu- n
ncleus of Meynert send innervations to orexin neurons
in the hypothalamus. We also found that the cholinergic r
tagonist carbachol activated a population of orexin neu-
rons (Figures 5A and 5C), so these cholinergic inner- pations might have an excitatory influence on these
eurons.
Eggermann et al. showed that orexins have a strong
nd direct excitatory effect on cholinergic neurons of
he basal forebrain through OX2R (Eggermann et al.,
001). These observations suggest that some popula-
ions of orexin neurons and cholinergic neurons in the
asal forebrain might send reciprocal excitatory projec-
ions to each other and form a positive feedback circuit.
onsidering the fact that cholinergic neurons are acti-
ated during wakefulness (Szymusiak et al., 2000), this
echanism might support sustained activation of
rexin neurons during wakefulness. One of the impor-
ant functions of the orexin neuron is stabilization and
onsolidation of wakefulness; loss of orexin signaling
eads to an inability to maintain wakefulness, a major
ymptom of narcolepsy. The positive feedback circuitry
etween the basal forebrain cholinergic neurons and
rexin neurons may contribute to the consolidation/sta-
ilization of behavioral states.
We also found that a small population (3%) of orexin
eurons was hyperpolarized by carbachol. This minor
opulation of orexin neurons might be negatively regu-
ated by cholinergic cells. We also found that the re-
aining orexin neurons did not respond to carbachol.
hese findings suggest that functional heterogeneity
xists among orexin neurons. The positive and negative
egulation by cholinergic neurons might have roles in
he regulation of orexin neurons according to vigilance
tates.
We also observed many neurons that were double
ositive for GFP-ir and ChAT-ir in the DMH of orexin/
TC::GFP transgenic mice (Figure 4E). Since the DMH
eceives direct and indirect SCN input, the SCN could
end indirect input to orexin neurons via the DMH neu-
ons to regulate the circadian timing of sleep, although
e did not observe GFP-ir cells in the SCN, suggesting
hat direct SCN projections to orexin neurons are
parse.
rexin Neurons Are Innervated by GABAergic
eurons in Preoptic Area
he hypnogenic function of the rostral hypothalamic re-
ion, particularly the VLPO, is well established on the
asis of lesioning, neuronal unit recording, and neuro-
hemical and thermal stimulation studies (McGinty and
zymusiak, 2003). The putative sleep factor, adenosine,
as found to excite sleep-active neurons in the VLPO
Chamberlin et al., 2003; Morairty et al., 2004; Strecker
t al., 2000). Neuronal recording studies also found that
here are many sleep-active neurons in the LPO and
PO, in which we found many GFP-positive cells in the
resent study (Alam et al., 1995; Koyama and Hayaishi,
994). These sleep-active neurons contain the inhibi-
ory neurotransmitters GABA and galanin. Our present
ork showed that GFP-ir cells in the VLPO also con-
ained GABA-ir (Figure 6B). We previously showed that
ABA potently and directly inhibits the activity of orexin
eurons (Li et al., 2002; Yamanaka et al., 2003a; Yama-
aka et al., 2003b). This suggests that sleep-active neu-
ons in the POA send inhibitory GABAergic projections
o orexin neurons during sleep. Consistent with this hy-
othesis, Yoshida et al. reported that the CSF orexin
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305level in rats exhibited marked diurnal fluctuation; the
level slowly increased during the dark period (active
phase in which wakefulness episodes are dominant)
and decreased during the light period (rest phase in
which sleep episodes are dominant) (Yoshida et al.,
2001). These findings are consistent with the hypothe-
sis that orexin neurons are inhibited by GABAergic inhi-
bition from the POA during sleep. Consistently, a recent
report showed that microdialysis perfusion of the pre-
optic area with a GABA agonist, muscimol, which de-
creased the sleep period of rats to less than 3% of the
baseline value over a 90 min period, induced expres-
sion of Fos in 36% of orexin neurons, suggesting that
subpopulations of the preoptic neurons send a tonic
inhibitory input to orexin neurons (Satoh et al., 2004).
These observations suggest that the activity of orexin
neurons is negatively regulated by GABAergic neurons
in the POA.
Regulation of Orexin Neurons by Serotonergic
Input from Raphe Nuclei
5-HT was initially thought to be a mediator of sleep,
because destruction of 5-HT neurons of the raphe nu-
clei, inhibition of 5-HT synthesis by p-chlorophenylala-
nine, or administration of 5-HT antagonists induces se-
vere insomnia, which is reversed by restoring 5-HT
synthesis (Adrien, 2002; Jouvet, 1999). In apparent con-
tradiction to this hypothesis, the electrical activity of
5-HT neurons is increased during wakefulness and de-
creased during both REM sleep and non-REM sleep
(Adrien, 2002). Furthermore, the DR sends inhibitory
projections to the VLPO sleep-active neurons, suggest-
ing that serotonergic neurons in the DR might have
roles in maintaining wakefulness (Chou et al., 2002;
Gallopin et al., 2000). These paradoxical observations
suggest complex physiological roles of 5-HT in sleep/
wakefulness regulation.
Our present study showed strong staining of TTC::
GFP fusion protein in the MnR (Figures 7A and 7B), and
most of these cells were also immunoreactive for 5-HT
(Figure 7D), suggesting that neurons in these regions
send serotonergic projections to orexin neurons, con-
sistent with retrograde tracing studies that revealed
that serotonergic neurons in the raphe nuclei project to
the hypothalamus (Leander et al., 1998; Petrov et al.,
1992). In our previous study, we found that 5-HT inhib-
ited 100% of orexin neurons examined (n = 81), by acti-
vating the G protein-coupled inward rectifier potassium
channel (GIRK) via activation of 5HT1A receptors (Mur-
aki et al., 2004). These observations indicate that sero-
tonergic neurons in the MnR send serotonergic inhibi-
tory input to orexin neurons.
Our present study suggests that orexin neurons are
innervated mainly by the MnR. In contrast, previous
studies suggested that orexin neurons mainly innervate
the DR in rats (Date et al., 1999; Nambu et al., 1999;
Peyron et al., 1998), in which we observed only few
GFP-positive cells in the present study. However, the
MnR and DR send reciprocal serotonergic inhibitory in-
nervation to each other via GABAergic interneurons.
Therefore, the activities of serotonergic cells in the MnR
and DR might be synchronized through disinhibition of
each other (Glass et al., 2003).It seems strange that wake-active 5-HT neurons
would inhibit wake-active orexin neurons. Therefore,
this innervation might act as a negative feedback regu-
lator of orexin neurons that maintains activity of orexin
neurons within an appropriate range during each be-
havioral state. This mechanism is consistent with the
observation that inhibition of the 5-HT system leads to
insomnia (Adrien, 2002).
Other Afferents to Orexin Neurons
We found many labeled neurons in the regions associ-
ated with emotion (see also Figure S3). The amygdala
contains many GFP-ir cells (Figures 3H and 3I). A con-
verging body of literature has implicated the amygdala
in assigning emotional significance or value to sensory
information. We also found many labeled neurons in the
other regions implicated in emotion, such as the IL,
AcbSh, LS, and BST. Especially, the BST contained
many strongly labeled neurons (Figure 3D; Figures S3E
and S3F). These pathways might be important to regu-
late the activity of orexin neurons upon emotional
stimuli to evoke emotional arousal or fear-related re-
sponses. The importance of these inputs is readily ap-
parent in the defense response, or “fight or flight” re-
sponse: in an awake and freely moving condition,
telemeter-indwelling orexin knockout mice showed di-
minished cardiovascular and behavioral responses to
emotional stress in the resident-intruder test (Kayaba
et al., 2003).
Strong, generally positive emotional stimuli are known
to trigger cataplexy in human narcolepsy patients. This
implies that orexin neurons may play a role in the physi-
ologic responses associated with emotions in humans,
and the neural circuits between the limbic system and
orexin neurons might be important for preventing
atonia during emotional stimulation in normal animals.
Rhesus monkeys with large bilateral lesions of the
amygdala had more sleep and a higher proportion of
REM sleep than control animals, suggesting that the
amygdala plays a role in sleep regulation (Benca et al.,
2000). Therefore, the innervation from the amygdala to
orexin neurons might also have some roles in the regu-
lation of sleep/wakefulness states. The innervations from
these regions might be also important in maintenance
of prolonged wakefulness during the active period by
conveying emotional stimuli to orexin neurons.
In the present study, we also found that the dorsal
motor nucleus of the vagus (DMX) contained several
retrogradely labeled cells. Terao et al. (2003) reported
increased GRp94 expression in the DMX during recov-
ery sleep after sleep deprivation (Terao et al., 2003).
These observations suggest the importance of the
DMX-orexin pathway for sleep/wakefulness regulation.
Orexin Neurons in Neural Pathways
that Control Sleep/Wakefulness
In the present study, we did not observe retrogradely
labeled cells in the LC, VTA, or TMN, and we observed
only few labeled cells in the DR and LDT/PPT. It might
be possible that these regions actually project to the
orexin cells, but for some reason, these cells did not
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iFigure 8. Schematic Drawing Showing Major Input and Output Sys-
tems of Orexin Neurons in the Network Implicated in the Regulation p
of Sleep/Wakefulness States f
tAcb, nucleus accumbens; Amyg, amygdala; Arc, arcuate nucleus;
BF, basal forebrain; BST, bed nucleus of the stria terminalis; PH, a
sposterior hypothalamus; POA, preoptic area; TMN, tuberomammil-
lary nucleus; LC, locus coeruleus; DR, dorsal raphe; MnR, median l
Iraphe; LDT, laterodorsal tegmental nucleus. Red lines show effer-
ents, while blue lines show afferents of orexin neurons. Purple lines
show other relevant neuronal pathways between important brain G
regions for sleep/wakefulness regulation. During wakefulness, in- T
nervation by cholinergic cells in the basal forebrain excites orexin a
neurons. Orexin neurons activate these cholinergic neurons, result- m
ing in a positive feedback loop that reinforces their activity. Orexin j
neurons might be also activated by the influences from the amyg- t
dala and the BST during wakefulness. Orexin neurons send excit- t
atory innervation to monoaminergic cells in the brainstem, includ- w
ing LC, DR, and TMN, and thereby elicit cortical arousal. l
Serotonergic cells in the DR and noradrenergic cells in the LC send p
inhibitory projections to POA sleep-active cells to further maintain o
wakefulness. Serotonergic neurons in the MnR send inhibitory pro- c
jections to orexin neurons; this innervation may act as a negative c
feedback system that limits activity of orexin neurons appropriately c
during wakefulness. During the sleep period, POA sleep-active
cells send inhibitory projections to cholinergic cells and orexin neu-
Hrons to silence these cells, which results in decreased activity of
Mmonoaminergic neurons in the brainstem.
t
l
ftake up the fusion protein, because this technique
pmight not show all input equally well. However, a study
swith a conventional retrograde tracer in the LHA, com-
d
bined with anterograde tracing in the LC or TMN, also t
showed that the LC and TMN provide little innervations h
Pto orexin neurons, suggesting the reliability of our pre-
wsent study (K. Yoshida, S. McCormack, R.A. España, A.
sCrocker, and T.E. Scammell, personal communication).
uThese observations suggest that the LC and TMN are
s
effector sites of orexin neurons, but these regions do l
not send direct feedback projections to orexin neurons.
GIn summary, our present study suggests that orexin
fneurons are activated by emotional stimuli from the lim-
bbic system and cholinergic influences from the basal
aforebrain during wakefulness to maintain the activity of
a
the monoaminergic system, while orexin neurons are (
inhibited by sleep-active neurons in the POA during s
wsleep (Figure 8). Orexin neurons, which link the rostral
tbrain regions and brainstem monoaminergic cells,
cmight be important for stabilizing behavioral states; this
aneural network ensures and stabilizes the “flip-flop”
w
mechanisms between the POA sleep-active neurons a
and monoaminergic neurons (Saper et al., 2001). The P
cnegative feedback pathway by serotonergic neurons inhe raphe nuclei might be also important for mainte-
ance of orexin neuron activity. Loss of the link be-
ween monoaminergic cells and VLPO sleep-active
eurons by orexin neurons might result in behavioral
nstability, which is a major symptom of narcolepsy.
xperimental Procedures
nimal Care
ll experimental procedures involving animals were approved by
he Animal Experiment and Use Committee of University of Tsu-
uba and were in accordance with NIH guidelines.
ransgenic Construct
2340 bp fragment of pCMV-IGFP.TTC (Maskos et al., 2002) result-
ng from digestion with SalI and PstI (partial) was subcloned in
Bluescript SK(−) (Stratagene) (pBlsc-IGFP::TTC). A BamHI-XbaI
ragment of the orexin/nlacZ transgene (Sakurai et al., 1999) con-
aining the murine protamine I gene, which provides an intron and
polyadenylation site, was ligated between the BamHI and XbaI
ites, and a 3.2 kb human orexin promoter (Sakurai et al., 1999) was
igated to the SalI site of pBlsc-IGFP::TTC, resulting in the orexin/
GFP::TTC transgene construct that we used in this study (Figure 1A).
eneration of Transgenic Mice
he transgene was excised by digesting the construct with XhoI
nd NotI, purified, and microinjected into pronuclei of fertilized
ouse oocytes (DBF1) to generate transgenic founders. We coin-
ected the orexin/nlacZ transgenic construct (Sakurai et al., 1999)
o coexpress a lacZ reporter gene as a marker of the cells in which
he transgene was transcribed. We obtained ten founder mice,
hich were bred to produce stable orexin/GFP::TTC transgenic
ines. Brains from the 8- to 12-week-old mice were tested for ex-
ression of the transgene product. We observed strong expression
f GFP fluorescence in the LHA from four lines by fluorescent mi-
roscopy. We selected three lines for further characterization, be-
ause these lines showed relatively strong expression of GFP as
ompared with the other lines.
istological Analysis
ice were anesthetized by intraperitoneal injection of sodium pen-
obarbital and perfused via the heart with phosphate-buffered sa-
ine (PBS), followed by 0.1 M phosphate buffer containing 4% para-
ormaldehyde. The whole brain was postfixed for 2 hr in 4%
araformaldehyde in PBS. For immunohistochemical study, cryo-
tat sections (40 m thick) were incubated for 35 min in 0.6% hy-
rogen peroxide to eliminate endogenous peroxide activity. Sec-
ions were incubated with 1% bovine serum albumin in PBS for 1
r and then incubated with rabbit anti-GFP antiserum (Molecular
robes) in the same solution for 1 hr at room temperature. Staining
as performed using the avidin-biotin-peroxidase method as de-
cribed previously (Nambu et al., 1999) or immunofluorescence
sing an Alexa 488-labeled secondary antibody (Invitrogen). We
tained 8 to 10 brains each from three independent transgenic
ines.
For double-immunofluorescence analysis of ChAT, 5-HT, TH,
ABA, and GFP, cryostat sections (40 m thick) were cut and post-
ixed with paraformaldehyde, incubated with 1% bovine serum al-
umin in PBS for 1 hr, and then incubated with goat anti-ChAT
ntibody (Chemicon), goat anti-5-HT antibody (Diasorin), mouse
nti-TH antibody (Chemicon), or mouse anti-GABA antibody
Sigma) together with rabbit anti-GFP antiserum (Clontech) in the
ame solution for 1 hr at room temperature. For detection of GABA,
e used colchicine-treated mouse brains. After being washed
hree times in PBS, the sections were incubated with Alexa 488-
onjugated donkey anti-rabbit IgG for 1 hr at room temperature
nd then washed three times in PBS. Then, tissues were incubated
ith an Alexa 594-conjugated secondary antibody (Cappel) for 1 hr
t room temperature. The slides were then washed three times in
BS and examined under a fluorescence microscope. We carefully
ompared the result obtained by staining the transgenic brains with
Afferents of Orexin Neurons
307that of wild-type littermates and judged it as positive when obvious
staining was observed in the transgenic sections only.
For in situ hybridization, GFP cDNA was amplified by PCR using
primers 5#-CGTCCTCCTTGAAGTCGATGC-3# and 5#-GCGAGGGC-
GATGCCACCTACG-3#, then cloned into pBluescript II KS(+) vector
(Stratagene). The sense or antisense GFP riboprobes were pre-
pared by in vitro transcription in the presence of digoxigenin (DIG)-
labeled CTP. Brain sections were incubated with the probes,
washed, and visualized by alkaline phosphatase-labeled anti-DIG
antibody and NBT/BCIP reagent. Sections were counterstained by
Kernechtrot solution (Mutoh Chemicals, Japan).
For immunoelectron microscopy, the vibratome sections were in-
cubated in 2% normal goat serum and then in anti-GFP antiserum
overnight. The sections were incubated with biotinylated anti-rab-
bit IgG and with ABC complex. The sections were treated with DAB
solution and fixed with 1% OsO4 in phosphate buffer, dehydrated
in ethanol, and embedded in Epon-Araldite. Ultrathin sections were
lightly stained with uranium acetate and lead citrate and examined
under an H-7000 electron microscope.
Whole-Cell Patch-Clamp Recording
The brains from orexin/EGFP mice (Yamanaka et al., 2003a) aged
2–4 weeks old were isolated in ice-cold cutting solution consisting
of sucrose (234 mM), KCl (2.5 mM), NaHPO4 (1.25 mM), MgSO4 (10
mM), CaCl2 (0.5 mM), NaHCO3 (26 mM), and D-glucose (10 mM)
bubbled with 95% O2 and 5% CO2. The brains were then cut coro-
nally into 250 m thick slices with a microtome (VTA-1000S, Leica,
Germany) in cutting solution. Slices containing the LHA were trans-
ferred to an incubation chamber filled with extracellular physiologi-
cal solution consisting of NaCl (125 mM), KCl (2.0 mM), CaCl2 (1
mM), MgCl2 (1 mM), NaHCO3 (26 mM), NaHPO4 (1.25 mM), and
D-glucose (10 mM) for at least 1 hr at room temperature (24°C–
26°C). For electrophysiological recording, the slices were transfer-
red to a recording chamber (RC-27L, Warner Instruments Corp.,
USA) at a controlled temperature of 34°C on a fluorescence micro-
scope stage (BX51WI, Olympus, Tokyo, Japan). The slices were su-
perfused with physiological solution, which was preheated before
entering the recording chamber by an in-line heater (Warner) at
34°C, at a rate of 3 ml/min using a peristaltic pump (Dynamax,
Rainin, CA). The fluorescence microscope was equipped with an
infrared camera (C2741-79, Hamamatsu Photonics, Hamamatsu,
Japan) for infrared differential interference contrast (IR-DIC) im-
aging and a CCD camera (IK-TU51CU, Olympus). Recording pi-
pettes were advanced while under positive pressure toward fluo-
rescent cells in the slice. The membrane patch was then ruptured
by suction, and the membrane current and potential were moni-
tored using an Axopatch 200B patch-clamp amplifier (Axon Instru-
ments, Foster City, CA) using a borosilicate pipette (3–6 MΩ after
heat polishing) filled with intracellular solution consisting of K-glu-
conate (130 mM), KCl (10 mM), CaCl2 (0.05 mM), MgCl2 (0.1 mM),
HEPES (10 mM), EGTA Na3 (0.5 mM), and Na2ATP (2 mM) (pH 7.4).
The pipette solution was aliquoted and stored at −80°C until re-
quired. The reference electrode was an Ag-AgCl pellet immersed
in bath solution. The liquid junction potential of the patch pipette
solution and perfused physiological solution was estimated to be
16 mV and was applied to the data. The output signal was low-
pass filtered at 2 kHz and digitized at 10 kHz. Data were recorded
on a computer through a Digidata 1322A A/D converter using
p-Clamp 8.0.1 software. The trace was processed for presentation
using Origin 6.1 (Origin Lab Corporation, Northampton, MA) and
Canvas 9.0 (Deneba, FL) software. Drugs were dissolved in extra-
cellular physiological solution and applied either by bath applica-
tion or by local application through a thin polyethylene tube posi-
tioned near the cells being recorded.
Supplemental Data
The Supplemental Data include three supplemental figures and can
be found with this article online at http://www.neuron.org/cgi/
content/full/46/2/297/DC1/.
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